INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

26,449 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
17
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$3.00M
17.9K sh
Apr 17, 2026Apr 21, 2026
Page 416 of 662
← PrevNext →
traded Apr 17, 2026
+4d
SEC Form 4

Evidence

17
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$6.01M
35.4K sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

17
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$7.85M
45.0K sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

16
BL
Bradbury Robyn LChief Financial Officer
CNMCore & Main, Inc.
Open-market sale · 10b5-1 plan
SELL$177K
3,353 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

16
VM
Valente ManuelaChief People Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$1,977
380 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

14
PM
Pearson MarkDirector, President and CEO
EQHEquitable Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$1.65M
39.7K sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

14
GV
Gupta VikramSee Remarks
SYNASYNAPTICS Inc
Open-market sale · 10b5-1 plan
SELL$125K
1,548 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

14
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$644K
3,662 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

13
VD
Van Well DaanChief Legal Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$3,554
684 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

13
CJ
Camblong JurgiDirector, Chief Executive Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$23K
4,486 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

13
MP
Menu PhilippeChief Medical Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$3,162
608 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

13
XZ
Xu ZhenyuChief Scientific Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$3,165
608 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

13
MR
Muken RossPresident
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$3,955
760 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

12
BL
Bradbury Robyn LChief Financial Officer
CNMCore & Main, Inc.
Open-market sale · 10b5-1 plan
SELL$86K
1,647 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

10
SB
Sevalia Piyush BSee Remarks
SITMSITIME Corp
Open-market sale · 10b5-1 plan
SELL$1.17M
2,419 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

8
GJ
Garateix Ernie JDirector, Chief Executive Officer
HRTGHeritage Insurance Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$221K
8,034 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

8
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$885K
1,543 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

8
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$806K
1,398 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

8
WW
Wasechek WayneEVP and CFO
RYNRAYONIER INC
Open-market sale · 10b5-1 plan
SELL$62K
2,920 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

8
LB
Lewis BryanDirector, CEO/President
IDNIntellicheck, Inc.
Open-market sale · 10b5-1 plan
SELL$85K
10.0K sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

8
AC
Ames Sophie CExec. Vice President & CHRO
QBTSD-Wave Quantum Inc.
Open-market sale · 10b5-1 plan
SELL$66K
3,070 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

8
CL
Collins Helen LouiseCHIEF MEDICAL OFFICER
ELVNEnliven Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$117K
2,441 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

8
CL
Collins Helen LouiseCHIEF MEDICAL OFFICER
ELVNEnliven Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$115K
2,419 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

8
GL
Gibbons Mary LourdesSVP and Chief Legal Officer
ESNTEssent Group Ltd.
Open-market sale · 10b5-1 plan
SELL$55K
872 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

7
LC
Llewellyn Lindsay CatherineSEE REMARKS
LYFTLyft, Inc.
Open-market sale · 10b5-1 plan
SELL$355K
23.7K sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

7
BJ
Binder Kurtis JosephCHIEF FINANCIAL OFFICER
ARLOArlo Technologies, Inc.
Open-market sale · 10b5-1 plan
SELL$380K
25.0K sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

7
GL
Gibbons Mary LourdesSVP and Chief Legal Officer
ESNTEssent Group Ltd.
Open-market sale · 10b5-1 plan
SELL$481K
7,628 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

5
KE
Kuhn Hallie E.EVP - Cap Market & Co-Lead -LS
AREALEXANDRIA REAL ESTATE EQUITIES, INC.
Open-market sale · 10b5-1 plan
SELL$26K
536 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence

5
GJ
Garateix Ernie JDirector, Chief Executive Officer
HRTGHeritage Insurance Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$8,521
300 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$589K
1,009 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$284K
488 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$573K
983 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$254K
442 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$289K
500 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$397K
687 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$282K
482 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$581K
1,010 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

4
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$504K
880 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

4
HM
Hoffmann MartinCEO
ONONOn Holding AG
Open-market sale · 10b5-1 plan
SELL$152K
4,150 sh
Apr 20, 2026Apr 21, 2026
traded Apr 20, 2026
+1dSEC Form 4

Evidence

3
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$13K
416 sh
Apr 17, 2026Apr 21, 2026
traded Apr 17, 2026
+4dSEC Form 4

Evidence